SCHEMBL10165915

SCHEMBL10165915

OC1CCC(Nc2ncc3cc[nH]c3n2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 10/20 0.56
▸ MAPK10 P53779 7/20 0.56
▸ MAPK9 P45984 8/20 0.49
▸ JUN P05412 1/20 0.48
▸ ULK1 O75385 1/20 0.46
▸ GSK3B P49841 3/20 0.46
▸ GSK3A P49840 2/20 0.46
▸ RIPK2 O43353 1/20 0.46
▸ ADORA1 P30542 3/20 0.45
▸ ADORA2A P29274 2/20 0.45
▸ ADORA2B P29275 2/20 0.45
▸ AXL P30530 1/20 0.45
▸ FLT3 P36888 1/20 0.45
▸ TYRO3 Q06418 1/20 0.45
▸ MERTK Q12866 1/20 0.45
▸ GAS6 Q14393 1/20 0.45
▸ MAP2K7 O14733 1/20 0.44
▸ IKBKB O14920 1/20 0.44
▸ MAPK13 O15264 1/20 0.44
▸ CDK2 P24941 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16266502 0.84 MAPK1 (0.53) MAPK8MAPK10MAPK9ULK1CDK2
SCHEMBL30346548 0.83 RET (0.47) MAPK8MAPK10MAPK9ULK1RET
SCHEMBL16802771 0.80 MAPK8 (0.66) MAPK8MAPK10MAPK9JUNGSK3B
SCHEMBL17910207 0.80 MAPK8 (0.66) MAPK8MAPK10MAPK9JUNGSK3B
SCHEMBL14391661 0.80 MAPK8 (0.57) MAPK8MAPK10MAPK9JUNGSK3B
SCHEMBL30407002 0.80 ULK1 (0.48) MAPK8MAPK10MAPK9ULK1RIPK2
SCHEMBL30649050 0.79 RIPK2 (0.55) MAPK8MAPK10MAPK9JUNGSK3B
SCHEMBL558138 0.76 MAPK8 (0.56) MAPK8MAPK10MAPK9JUNGSK3B
SCHEMBL558139 0.76 MAPK8 (0.56) MAPK8MAPK10MAPK9JUNGSK3B
SCHEMBL30406752 0.75 LRRK2 (0.39) MAPK8MAPK10MAPK9ULK1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2012-02-09 — — US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 — — US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 MAPK8 20/4885MAPK10 32/4885MAPK9 62/4885
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 MAPK8 20/4885MAPK10 32/4885MAPK9 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback